Psych Congress Elevate 2024 Digital Brochure - 15

Treatment-Resistant
Depression: Are RapidActing
Antidepressants
Just the Beginning?
2:45 PM-3:45 PM
Julie carbraY, phd, aprn; kristian
daMbrino, Msn, aprn, pMhnp-bc
PsychoPharmacology
This presentation focuses on the crucial role of
NMDA and AMPA receptors and the significance of
glutamate pathways in the context of depression
treatment. It will highlight the current pharmacodynamics
and clinical applications of groundbreaking
treatments such as esketamine, ketamine, bupropion-dextromethorphan,
and zuranolone, offering
promising avenues in rapid-acting depression
management. The session critically assesses precision
psychiatry in the context of treatment-resistant
depression, discussing AI-identified biomarkers
and advanced analytics for personalized treatment
strategies.
What Came First: Psychosis or
Cannabis Use? Helping Patients
with Co-occurring Psychosis and
Cannabis Use Disorder
andrew penn, Ms, pMhnp; Jonathan
williaMs, dnp, pMhnp-bc
PsychoPharmacology
Cannabis, as one of the most widely used psychoactive
substances, has garnered increased
attention, particularly with the legalization of recreational
use in many states in the US. This session
will delve into the intricate connection between
cannabis use and psychosis, shedding light on the
complex interplay between them in order to equip
clinicians with a comprehensive understanding of
the literature, empower them to identify potential
risks and benefits associated with cannabis use,
engage in effective patient communication, and
provide tailored education to reduce harm associated
with cannabis use.
1:25 PM-2:35 PM
l unch i nnov ation
t heaters
(non- accredited )
Lunch will be served. Seating is limited to 200
attendees and will be available on a first-come, firstserved
basis. Please plan to arrive early to ensure a
seat. No CE credits are offered at these programs.
MasterClass
These highly interactive educational sessions
offer a comprehensive and practical
look into a diverse array of mental health
conditions. With a focus on translating
current research into practical, real-world
applications, these sessions will help you to
effectively integrate the latest advances in
mental healthcare into clinical practice, enhancing
your professional skills and improving
patient outcomes. Both seasoned and
early-career mental health professionals will
benefit from these educational grant-supported
sessions. This accredited session
will be supported via an educational grant.
Applications for commercial support from
healthcare-related industries are pending.
Commercial support will be acknowledged
as it is received.
3:55 PM-4:55 PM
Forget the Future, How Do
I Help My Patients with
Schizophrenia TODAY?
craig chepke, Md, dFapa; rebecca
kraus barbee, Mspas, pa-c, caQ-psYch
PsychoPharmacology
Schizophrenia is a complex disorder with numerous
treatment challenges for clinicians. Although
there are many exciting medications and interventions
in the psychiatric pipeline for the treatment
of schizophrenia, these treatments are not yet
available to help patients. This presentation aims to
provide evidence-based guidance on navigating
these real-world challenges to maximize the quality
of life for our patients.
Launching into Uncharted Territory:
Strategies for Success in Private
Practice
desiree Matthews, pMhnp-bc; kevin
williaMs, Ms, Mpas, pa-c
Practice/ProfessioNal
maNagemeNt
Starting and running a private practice requires
careful planning and strategic decision making.
This session offers a comprehensive guide to aspiring
practitioners, covering essential topics such
as structuring the business, navigating insurance
considerations, and effectively managing the clinic's
financial health. Attendees will gain practical
insights and expert advice on the key elements
necessary for success in establishing and sustaining
a thriving private practice.
Unlocking the Power of Ketamine:
What You Need to Know
sandhYa prashad, Md
PsychoPharmacology
Ketamine and esketamine have been heralded as
one of the greatest breakthroughs in depression
treatment. Yet the optimal administration methods
and personalized treatment strategies vary greatly
depending on individual patient diagnoses and
symptom severity. This session will offer a comprehensive
examination of ketamine's role within the
broader treatment landscape, delving into various
administration routes and real-world outpatient
practice. Attendees will gain insights into treatment
indications, supported by relevant research,
and also discuss crucial treatment factors like
patient readiness, contraindications, anticipated
outcomes, and the inclusion of psychotherapy.
5:05 PM-6:05 PM
Opening Reception in
Exhibit Hall
Join your peers in the Exhibit Hall to
engage with mentors, recruiters, and future
employers and learn about available pharmaceuticals
and devices for your practice.
Have your CV reviewed by a hiring expert
(booth #319), get a professional headshot
taken by our photographer (booth #330),
and more!
Visit the Psych Congress Elevate booth
(#222) to register with an exclusive Alumni
rate for 2025 and to learn more about our
other Psych Congress events.
5:45 PM-6:05 PM
DJ and Karaoke
Join your peers and faculty
for Elevate's Got Talent!
6:35 PM-9:35 PM
Elevate Takes Las Vegas
Join us after the conference at Beer Park at
the Paris Las Vegas for drinks, games, and
networking! Eat, drink, and mingle with
your peers, faculty, and steering committee
members while enjoying views of the Las
Vegas Strip.
Psych Congress Elevate 2024 Digital Brochure

Table of Contents for the Digital Edition of Psych Congress Elevate 2024 Digital Brochure
